Real-world adherence for direct oral anticoagulants in a newly diagnosed atrial fibrillation cohort: does the dosing interval matter?
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2261
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Real-world adherence for direct oral anticoagulants in a newly diagnosed atrial fibrillation cohort: does the dosing interval matter? ; volume:19 ; number:1 ; day:19 ; month:3 ; year:2019 ; pages:1-10 ; date:12.2019
BMC cardiovascular disorders ; 19, Heft 1 (19.3.2019), 1-10, 12.2019
- Urheber
-
Pham, Phuong N.
Brown, Joshua D.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12872-019-1033-3
- URN
-
urn:nbn:de:101:1-2019041122112377948073
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pham, Phuong N.
- Brown, Joshua D.
- SpringerLink (Online service)
Ähnliche Objekte (12)
New Anticoagulants for Atrial Fibrillation
New Anticoagulants for Atrial Fibrillation
The Importance of Appropriate Dosing of Nonvitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation
Impact of Newly Diagnosed Cancer on Bleeding Events in Patients with Atrial Fibrillation Treated with Direct Oral Anticoagulants
Cellular adhesion differences at a blood brain barrier model between Natalizumab (Tysabri) standard interval dosing and extended interval dosing therapy
Initial rivaroxaban dosing in patients with atrial fibrillation
Initial apixaban dosing in patients with atrial fibrillation
Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
Guideline-discordant dosing of direct-acting oral anticoagulants in the veterans health administration
Direct Oral Anticoagulants in Atrial Fibrillation: Practical Considerations and Remaining Issues
Atrial Fibrillation, Oral Anticoagulants, and Concomitant Active Cancer: Benefits and Risks
Prevalence of atrial fibrillation and reasons for undertreatment with oral anticoagulants
New Anticoagulants for Atrial Fibrillation
New Anticoagulants for Atrial Fibrillation
The Importance of Appropriate Dosing of Nonvitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation
Impact of Newly Diagnosed Cancer on Bleeding Events in Patients with Atrial Fibrillation Treated with Direct Oral Anticoagulants
Cellular adhesion differences at a blood brain barrier model between Natalizumab (Tysabri) standard interval dosing and extended interval dosing therapy
Initial rivaroxaban dosing in patients with atrial fibrillation
Initial apixaban dosing in patients with atrial fibrillation
Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
Guideline-discordant dosing of direct-acting oral anticoagulants in the veterans health administration
Direct Oral Anticoagulants in Atrial Fibrillation: Practical Considerations and Remaining Issues
Atrial Fibrillation, Oral Anticoagulants, and Concomitant Active Cancer: Benefits and Risks
Prevalence of atrial fibrillation and reasons for undertreatment with oral anticoagulants
New Anticoagulants for Atrial Fibrillation
New Anticoagulants for Atrial Fibrillation
The Importance of Appropriate Dosing of Nonvitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation
Impact of Newly Diagnosed Cancer on Bleeding Events in Patients with Atrial Fibrillation Treated with Direct Oral Anticoagulants
Cellular adhesion differences at a blood brain barrier model between Natalizumab (Tysabri) standard interval dosing and extended interval dosing therapy
Initial rivaroxaban dosing in patients with atrial fibrillation
Initial apixaban dosing in patients with atrial fibrillation
Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
Guideline-discordant dosing of direct-acting oral anticoagulants in the veterans health administration
Direct Oral Anticoagulants in Atrial Fibrillation: Practical Considerations and Remaining Issues
Atrial Fibrillation, Oral Anticoagulants, and Concomitant Active Cancer: Benefits and Risks